Trial Outcomes & Findings for To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population (NCT NCT02937636)
NCT ID: NCT02937636
Last Updated: 2019-06-14
Results Overview
The BI was performed by a single examiner using a color coded periodontal probe. The probe was inserted approximately 1 mm into the gingival crevice. A moderate pressure was used whilst sweeping from interproximal to interproximal along the sulcular epithelium. The BI scoring system to be used is as follows: 0= No bleeding after 30 seconds; 1= Bleeding upon probing after 30 seconds; 2= Immediate bleeding observed. This measure will be analyzed and summarized over all sites.
COMPLETED
NA
128 participants
At Week 12
2019-06-14
Participant Flow
Participants were recruited from one center in China.
A total of 343 participates were screened, out of which 128 participants were randomized in the study. 215 participants were not randomized as 186 participants did not meet study criteria, 5 participants withdrew consent and 24 were not randomized for other reasons (not specified).
Participant milestones
| Measure |
Test Product
Participants applied a full strip of dentifrice containing 0.454% weight by weight (w/w) stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 parts per million (ppm) fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
Reference Product
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
|---|---|---|
|
Overall Study
STARTED
|
63
|
65
|
|
Overall Study
COMPLETED
|
60
|
63
|
|
Overall Study
NOT COMPLETED
|
3
|
2
|
Reasons for withdrawal
| Measure |
Test Product
Participants applied a full strip of dentifrice containing 0.454% weight by weight (w/w) stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 parts per million (ppm) fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
Reference Product
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
|---|---|---|
|
Overall Study
Other (Not specified)
|
3
|
2
|
Baseline Characteristics
To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population
Baseline characteristics by cohort
| Measure |
Test Product
n=63 Participants
Participants applied a full strip of dentifrice containing 0.454% w/w stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 ppm fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
Reference Product
n=65 Participants
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
Total
n=128 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Customized
|
40.8 Years
STANDARD_DEVIATION 10.20 • n=99 Participants
|
42.9 Years
STANDARD_DEVIATION 10.04 • n=107 Participants
|
41.9 Years
STANDARD_DEVIATION 10.13 • n=206 Participants
|
|
Sex: Female, Male
Female
|
51 Participants
n=99 Participants
|
52 Participants
n=107 Participants
|
103 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
12 Participants
n=99 Participants
|
13 Participants
n=107 Participants
|
25 Participants
n=206 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Asian
|
63 Participants
n=99 Participants
|
65 Participants
n=107 Participants
|
128 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Stratification n (%)
Male, Smoker, Baseline MGI <= 2.00
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Stratification n (%)
Male, Smoker, Baseline MGI > 2.00
|
1 Participants
n=99 Participants
|
1 Participants
n=107 Participants
|
2 Participants
n=206 Participants
|
|
Stratification n (%)
Male, non-smoker, Baseline MGI <= 2.00
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Stratification n (%)
Male, non-smoker, Baseline MGI > 2.00
|
11 Participants
n=99 Participants
|
12 Participants
n=107 Participants
|
23 Participants
n=206 Participants
|
|
Stratification n (%)
Female, Smoker, Baseline MGI <= 2.00
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Stratification n (%)
Female, Smoker, Baseline MGI > 2.00
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Stratification n (%)
Female, non-smoker, Baseline MGI <= 2.00
|
4 Participants
n=99 Participants
|
3 Participants
n=107 Participants
|
7 Participants
n=206 Participants
|
|
Stratification n (%)
Female, non-smoker, Baseline MGI > 2.00
|
47 Participants
n=99 Participants
|
49 Participants
n=107 Participants
|
96 Participants
n=206 Participants
|
PRIMARY outcome
Timeframe: At Week 12Population: The intent to treat (ITT) (n=128) population is defined as those participants who were randomized, received at least one dose of study product and had at least one post-baseline efficacy measurement.
The BI was performed by a single examiner using a color coded periodontal probe. The probe was inserted approximately 1 mm into the gingival crevice. A moderate pressure was used whilst sweeping from interproximal to interproximal along the sulcular epithelium. The BI scoring system to be used is as follows: 0= No bleeding after 30 seconds; 1= Bleeding upon probing after 30 seconds; 2= Immediate bleeding observed. This measure will be analyzed and summarized over all sites.
Outcome measures
| Measure |
Test Product
n=63 Participants
Participants applied a full strip of dentifrice containing 0.454% w/w stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 ppm fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
Reference Product
n=65 Participants
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
|---|---|---|
|
Mean Bleeding Index (BI)
|
0.07 Score on Scale
Standard Deviation 0.059
|
0.15 Score on Scale
Standard Deviation 0.128
|
SECONDARY outcome
Timeframe: At Week 12Population: The ITT (n=128) population is defined as those participants who were randomized, received at least one dose of study product and had at least one post-baseline efficacy measurement.
Number of bleeding sites were measured as BI via a single examiner using a color coded periodontal probe. The probe was gently inserted approximately 1 millimeter (mm) into the gingival crevice. A moderate pressure was used whilst sweeping from interproximal to interproximal along the sulcular epithelium. The BI scoring system used to measure bleeding sites is as follows: 0= No bleeding after 30 seconds; 1= Bleeding upon probing after 30 seconds; 2= Immediate bleeding observed. A bleeding site was considered as a BI score of 1 or 2.
Outcome measures
| Measure |
Test Product
n=63 Participants
Participants applied a full strip of dentifrice containing 0.454% w/w stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 ppm fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
Reference Product
n=65 Participants
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
|---|---|---|
|
Number of Bleeding Sites
|
10.37 Number of bleeding sites
Standard Deviation 8.499
|
20.92 Number of bleeding sites
Standard Deviation 15.881
|
SECONDARY outcome
Timeframe: At Week 12Population: The ITT (n=128) population is defined as those participants who were randomized, received at least one dose of study product and had at least one post-baseline efficacy measurement.
The MGI was assessed on facial and lingual surfaces at two sites on each tooth (papillae and margin).The scoring of MGI was performed by a single examiner. The MGI scoring system is as follows:0=absence of inflammation;1=mild inflammation; slight change in color, little change in color; little change in texture of any portion of the marginal or papillary gingival unit;2=mild inflammation; criteria as above but involving the entire marginal or papillar gingival units;3=moderate inflammation; glazing, redness, edema, and/or hypertrophy of the marginal or papillary gingival unit;4=severe inflammation; marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration.
Outcome measures
| Measure |
Test Product
n=63 Participants
Participants applied a full strip of dentifrice containing 0.454% w/w stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 ppm fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
Reference Product
n=65 Participants
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
|---|---|---|
|
Mean Modified Gingival Index (MGI)
|
1.62 Score On Scale
Standard Deviation 0.211
|
1.89 Score On Scale
Standard Deviation 0.198
|
SECONDARY outcome
Timeframe: At Week 12Population: The ITT (n=128) population is defined as those participants who were randomized, received at least one dose of study product and had at least one post-baseline efficacy measurement.
The dental examiner used the PI to assess plaque on all gradable teeth. The plaque was first disclosed using a dye solution. Participants then rinsed with disclosing solution according to instructions. Plaque was assessed with each tooth being divided into 6 areas including the mesiofacial, facial, distofacial, mesiolingual, lingual and distolingual surfaces. Disclosed plaque was scored as follows: 0= No plaque; 1= Slight flecks of plaque at the cervical margin of the tooth; 2= A thin continuous band of plaque (1 mm or smaller) at the cervical margin of the tooth; 3= A band of plaque wider than 1 mm but covering less than 1/3 of the crown of the tooth; 4= Plaque covering at least 1/3 but less tan 2/3 of the crown of the tooth; 5= Plaque covering 2/3 or more of the crown of the tooth.Overall PI score and interproximal PI score were calculated as the mean PI over all tooth sites and mean PI over interproximal sites (distal and mesial) respectively.
Outcome measures
| Measure |
Test Product
n=63 Participants
Participants applied a full strip of dentifrice containing 0.454% w/w stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 ppm fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
Reference Product
n=65 Participants
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
|---|---|---|
|
Mean Plaque Index (PI) (Overall and Interproximal)
Mean Plaque Index (PI) (overall)
|
1.85 Score on Scale
Standard Deviation 0.319
|
2.19 Score on Scale
Standard Deviation 0.245
|
|
Mean Plaque Index (PI) (Overall and Interproximal)
Mean Plaque Index (PI) (interproximal)
|
1.92 Score on Scale
Standard Deviation 0.313
|
2.24 Score on Scale
Standard Deviation 0.240
|
Adverse Events
Test Product
Reference Product
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Test Product
n=63 participants at risk
Participants applied a full strip of dentifrice containing 0.454% w/w stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 ppm fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
Reference Product
n=65 participants at risk
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
|
|---|---|---|
|
Gastrointestinal disorders
SENSITIVITY OF TEETH
|
1.6%
1/63 • Number of events 1 • 12 Weeks
|
0.00%
0/65 • 12 Weeks
|
|
Gastrointestinal disorders
STOMATITIS
|
1.6%
1/63 • Number of events 1 • 12 Weeks
|
0.00%
0/65 • 12 Weeks
|
|
Gastrointestinal disorders
APHTHOUS ULCER
|
0.00%
0/63 • 12 Weeks
|
1.5%
1/65 • Number of events 1 • 12 Weeks
|
|
Infections and infestations
ORAL HERPES
|
1.6%
1/63 • Number of events 1 • 12 Weeks
|
0.00%
0/65 • 12 Weeks
|
|
Infections and infestations
NASOPHARYNGITIS
|
0.00%
0/63 • 12 Weeks
|
1.5%
1/65 • Number of events 1 • 12 Weeks
|
|
Infections and infestations
PHARYNGITIS
|
0.00%
0/63 • 12 Weeks
|
1.5%
1/65 • Number of events 1 • 12 Weeks
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
- Publication restrictions are in place
Restriction type: OTHER